Terapin
PrivateLast Round
Private Equity
Aug 1, 2022
Est. Valuation
$58.62M
Total Funding Raised
$167.66M
Company Overview
Terapin is a digital content company that specializes in the production, distribution, and monetization of webtoons, web novels, and character intellectual property.
Sector
Media, Entertainment & Gaming
Verticals
Content Creation, Digital Publishing, Streaming Platforms, Creator Economy
Business Model
B2C
Customer Profile
Subscription SaaS, Revenue Share, Freemium
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Terapin Comparables
Compare Terapin with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TOPCO CO., LTD. | 82% | |
| SK Telecom | 79% | |
| Kakao Corp. | 78% | |
Terapin Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Aug 1, 2022 | ||||
| Private Equity | Jan 14, 2022 | ||||
| VC Round | Sep 14, 2021 | ||||
| Series B | Apr 21, 2021 | ||||
| Series A Extension | Jun 21, 2020 | ||||
Series A | Nov 13, 2019 |
Terapin Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DA Value Investment | Series A Extension, Series A |
| Hyundai Investment Partners | Series B, Series A Extension, Series A |
| KB Investment | Series B, Series A Extension, Series A |
| Wonik Investment Partners | Series B, Series A Extension |
| Affirma Capital | Private Equity |
| NPX Capital | Private Equity, VC Round |
| Daekyo Investment | Series B, Series A Extension, Series A, Private Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2022
$93M round with Affirma Capital and NPX Capital.
- Jan 14, 2022
$55M round led by NPX Capital.
Terapin Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Terapin's valuation, stock price, and market status.